Stryker Corp
(LTS:0R2S)
$
368.76
-1.8075 (-0.49%)
Market Cap: 139.87 Bil
Enterprise Value: 150.67 Bil
PE Ratio: 39.32
PB Ratio: 6.94
GF Score: 93/100 Stryker Corp at Wells Fargo Healthcare Conference Transcript
Sep 07, 2023 / 05:30PM GMT
Release Date Price:
$296.97
Lawrence H. Biegelsen
Wells Fargo Securities, LLC, Research Division - Senior Medical Device Equity Research Analyst
I'm Larry Biegelsen, the medical device analyst at Wells Fargo, and it's my pleasure to host this session with Stryker. From the company, we have Glenn Boehnlein, the CFO; and Jason Beach, the Vice President of Investor Relations.
In terms of format, it's going to be a fireside chat. If anybody has a question, just raise your hand. We'll come around with a mic. Glenn and Jason, thanks so much for being here. Thank you.
Glenn S. Boehnlein
Stryker Corporation - VP & CFO
Thank you. Thanks for having us.
Questions & Answers
Lawrence H. Biegelsen
Wells Fargo Securities, LLC, Research Division - Senior Medical Device Equity Research Analyst
So someone -- Louis, can you close the door, please? Can someone just close the door? Thanks. So let's start, Glenn, at a high level here. Stryker had a really impressive first half, I think 12% organic growth. Could you talk about the momentum
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot